Status:

RECRUITING

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Lead Sponsor:

Takeda

Conditions:

Cytomegalovirus (CMV)

Kidney Disease

Eligibility:

All Genders

18+ years

Brief Summary

The main aim of this study is to assess the safety of maribavir in adults with severe CKD or comorbid ESRD including participants on artificial filtering of the kidney (dialysis) or the blood (hemodia...

Eligibility Criteria

Inclusion

  • Adults more than and equal to (≥) 18 years of age at index date.
  • Diagnosis of comorbid ESRD or comorbid severe CKD prior to the index date.
  • If ESRD (including participants on peritoneal dialysis or hemodialysis): participant diagnosed with ESRD confirmed by an estimated glomerular filtration rate (eGFR) less than (\<) 15 milliliters per minute per 1.73 square meters (mL/min/1.73m\^2).
  • If severe CKD: participant diagnosed with severe CKD confirmed by an eGFR of 15 to \<30 mL/min/1.73m\^2 at index.
  • Participant has undergone solid organ transplant (SOT) or hematopoietic stem cell transplantation (HSCT) before index date.
  • Participant was diagnosed with refractory (with or without resistance) CMV during the latest post-transplant period.
  • Participant initiated treatment with maribavir in routine practice within the eligibility period and received at least 1 dose of maribavir.
  • Informed consent provided (where required by local regulations) before data collection commences.

Exclusion

  • There are no exclusion criteria for this study.

Key Trial Info

Start Date :

November 3 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2027

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06243731

Start Date

November 3 2025

End Date

January 31 2027

Last Update

December 16 2025

Active Locations (25)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (25 locations)

1

Hopital Erasme - PPDS

Anderlecht, Brussels Capital, Belgium, 1070

2

UZ Leuven - PPDS

Leuven, Vlaams Brabant, Belgium, 3000

3

North Estonia Medical Centre Foundation

Tallinn, Harju, Estonia, 13419

4

Tartu University Hospital

Tartu, Estonia, 60535